Drug
Centhaquine
Centhaquine is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Not yet recruiting2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (50.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
Trials by Status
completed125%
recruiting125%
not_yet_recruiting250%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
NCT05241067
recruitingphase_4
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
NCT05956418
not_yet_recruitingphase_3
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
NCT05251181
completedphase_2
PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
NCT04056065
Clinical Trials (4)
Showing 4 of 4 trials
NCT05241067Phase 2
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
NCT05956418Phase 4
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
NCT05251181Phase 3
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
NCT04056065Phase 2
PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4